nav4694
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01680588)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Payload
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- nav4694
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05361382 | Phase 1 | Nov 23, 2021 | National Institute on Aging (NIA), University of Pittsburgh |
| NCT01886820 | Phase 3 | Jun 1, 2013 | Navidea Biopharmaceuticals |
| NCT01812213 | Phase 2 | Mar 1, 2013 | Navidea Biopharmaceuticals |
| NCT01680588 | Phase 2 | Aug 1, 2012 | Navidea Biopharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals | For profit | 3 | 3 | 2 | 2012 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2021 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1